Control over critical COVID-19: Acute hypoxaemic respiratory system failure and COVID-19 – who.int


Overview

WHO recommends prompt recognition of progressive acute hypoxaemic respiratory system failure whenever a patient with respiratory system distress is failing to reply to standard oxygen therapy and sufficient preparation to supply advanced oxygen/ventilatory support.

Hypoxaemic respiratory system failure in ARDS generally is a result of intrapulmonary ventilation-perfusion mismatch or shunt in most cases requires mechanical ventilation.

Anytime, should there be urgent or emergent indications for intubation, do not hesitate.

We advise prompt recognition of progressive acute hypoxaemic respiratory system failure whenever a patient with respiratory system distress is failing to reply to standard oxygen therapy and sufficient preparation to supply advanced oxygen/ventilatory support.

WHO shows that patients with severe or critical COVID-19 with acute hypoxaemic respiratory system failure that don’t require emergent intubation be given HFNO, or CPAP or NIV (BiPAP) over standard oxygen therapy.

Source